| Chemical conjugation strategies for the development of protein-based subunit nanovaccines L Lu, VT Duong, AO Shalash, M Skwarczynski, I Toth Vaccines 9 (6), 563, 2021 | 77 | 2021 |
| Cyclic dipeptides: The biological and structural landscape with special focus on the anti-cancer proline-based scaffold J Bojarska, A Mieczkowski, ZM Ziora, M Skwarczynski, I Toth, AO Shalash, ... Biomolecules 11 (10), 1515, 2021 | 73 | 2021 |
| Poly(hydrophobic amino acid)-Based Self-Adjuvanting Nanoparticles for Group A Streptococcus Vaccine Delivery A Azuar, Z Li, MA Shibu, L Zhao, Y Luo, AO Shalash, ZG Khalil, RJ Capon, ... Journal of Medicinal Chemistry 64 (5), 2648-2658, 2021 | 40 | 2021 |
| Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content AO Shalash, AM Molokhia, MMA Elsayed European journal of pharmaceutics and biopharmaceutics 96, 291-303, 2015 | 35 | 2015 |
| Key considerations for the development of safe and effective SARS‐CoV‐2 subunit vaccine: A peptide‐based vaccine alternative AO Shalash, WM Hussein, M Skwarczynski, I Toth Advanced Science 8 (16), 2100985, 2021 | 26 | 2021 |
| The relationship between the permeability and the performance of carrier-based dry powder inhalation mixtures: new insights and practical guidance AO Shalash, NM Khalafallah, AM Molokhia, MMA Elsayed Aaps Pharmscitech 19, 912-922, 2018 | 25 | 2018 |
| A new role of fine excipient materials in carrier-based dry powder inhalation mixtures: effect on deagglomeration of drug particles during mixing revealed AO Shalash, MMA Elsayed AAPS PharmSciTech 18 (8), 2862-2870, 2017 | 25 | 2017 |
| Modeling the performance of carrier-based dry powder inhalation formulations: Where are we, and how to get there? MMA Elsayed, AO Shalash Journal of Controlled Release 279, 251-261, 2018 | 24 | 2018 |
| Oral peptide vaccine against hookworm infection: correlation of antibody titers with protective efficacy AO Shalash, L Becker, J Yang, P Giacomin, M Pearson, WM Hussein, ... Vaccines 9 (9), 1034, 2021 | 18 | 2021 |
| Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2 M Pandey, V Ozberk, S Eskandari, AO Shalash, MA Joyce, HA Saffran, ... Clinical & Translational Immunology 10 (3), e1260, 2021 | 16 | 2021 |
| Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems AO Shalash, A Azuar, HYR Madge, N Modhiran, AA Amarilla, B Liang, ... Pharmaceutics 14 (4), 856, 2022 | 11 | 2022 |
| Detection and quantification of SARS-CoV-2 receptor binding domain neutralization by a sensitive competitive ELISA assay AO Shalash, A Azuar, HYR Madge, N Modhiran, AA Amarilla, B Liang, ... Vaccines 9 (12), 1493, 2021 | 11 | 2021 |
| Polymeric Nanoparticles as a Self-Adjuvanting Peptide Vaccine Delivery System: The Role of Shape P Koirala, SPR Chen, JC Boer, ZG Khalil, C Deceneux, G Goodchild, L Lu, ... Adv. Funct. Mater., 0 | 11* | |
| Development of a peptide vaccine against hookworm infection: Immunogenicity, efficacy, and immune correlates of protection AO Shalash, L Becker, J Yang, P Giacomin, M Pearson, WM Hussein, ... Journal of Allergy and Clinical Immunology 150 (1), 157-169. e10, 2022 | 9 | 2022 |
| Hookworm infection: Toward development of safe and effective peptide vaccines AO Shalash, WM Hussein, M Skwarczynski, I Toth Journal of Allergy and Clinical Immunology 148 (6), 1394-1419. e6, 2021 | 9 | 2021 |
| Insights into the potential of rheological measurements in development of dry powder inhalation formulations K Almansour, IM Alfagih, AO Shalash, K Brockbank, R Ali, T Freeman, ... International Journal of Pharmaceutics 614, 121407, 2022 | 7 | 2022 |
| Critical attributes of fine excipient materials in carrier-based dry powder inhalation formulations: The particle shape and surface properties MMA Elsayed, IM Alfagih, K Brockbank, AH Aodah, R Ali, K Almansour, ... International Journal of Pharmaceutics 655, 123966, 2024 | 5 | 2024 |
| The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2 AO Shalash, I Toth, M Skwarczynski Drug Development Research 83 (6), 1251-1256, 2022 | 5 | 2022 |
| Polymeric Nanoparticles as Oral and Intranasal Peptide Vaccine Delivery Systems: The Role of Shape and Conjugation P Koirala, AO Shalash, SPR Chen, MO Faruck, J Wang, WM Hussein, ... Vaccines 12 (2), 198, 2024 | 4 | 2024 |
| Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A Streptococcus Vaccine Delivery Systems S Jin, J Zhang, UJ Nahar, W Huang, NA Alharbi, AO Shalash, P Koirala, ... ACS Infectious Diseases 9 (8), 1570-1581, 2023 | 3 | 2023 |
